Shekunova EV, Kashkin VA, Muzhikyan Acapital AC, Makarova MN, Balabanyan VY, Makarov VG (2020) Therapeutic efficacy of arginine-rich exenatide on diabetic neuropathy in rats
2, 2023, but so far, no settlements have been reached
the potential to violate what WADA defines in its code as the spirit of sport. There is a divide in the anti-doping world over whether violating the spirit of sport is too vague a criterion, and that enforcement should be based on science alone
The first strategy, exenatide was the first GLP-1 analog introduced for the treatment of patients with type 2 diabetes
Een van de meest directe effecten van GLP-1 medicatie is juist dat deze ruis wegvalt
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial